Histamine Intolerance

Histamine intolerance and MCAS overlap clinically but they're not the same condition. The distinction matters for treatment — and most patients with food-triggered symptoms have one or the other, sometimes both.

What patients tell us

“I react to wine, aged cheese, leftovers, fermented foods. Headache, flushing, congestion, sometimes hives. The reactions are worse around my period. I've cut out the obvious foods and I'm better, but I'm not sure what's actually happening or how to broaden my diet again.”

What histamine intolerance is

Histamine intolerance describes a clinical pattern in which patients experience symptoms in response to histamine-containing foods or histamine-releasing triggers, attributed to an imbalance between histamine input and the body's capacity to break it down. The primary enzyme responsible for histamine degradation in the gut is diamine oxidase (DAO); secondary degradation occurs through histamine N-methyltransferase. When DAO activity is insufficient relative to histamine load, symptoms result.

Histamine is present in many foods — produced by bacterial fermentation in aged, cured, and fermented products, accumulated in foods that have been stored, and present naturally in some fresh foods. Other foods, while not high in histamine themselves, are histamine-releasing — they trigger mast cell degranulation that releases endogenous histamine.

Why histamine intolerance and MCAS aren't the same condition

Both conditions involve histamine, both produce similar symptoms in many patients, and both can coexist. MCAS is fundamentally about mast cell hyperactivity — mast cells releasing too many mediators in response to too many triggers; the treatment focus is mast cell stabilization. Histamine intolerance is more specifically about histamine balance — adequate intake or release of histamine overwhelming inadequate degradation capacity; the treatment focus is reducing histamine load and supporting degradation. In practice, the distinction is sometimes clean and sometimes not, and many patients fall in between, requiring clinical judgment.

The factors that affect DAO activity

Gut health is central — DAO is produced primarily in the small intestinal mucosa, and conditions affecting gut barrier function reduce DAO activity. Genetic variants affect baseline enzyme activity. Estrogen affects histamine metabolism — higher estrogen is associated with both increased histamine release and decreased DAO activity, which is why many patients experience worse symptoms during specific phases of the menstrual cycle. Certain medications inhibit DAO. Gut microbiome composition matters, as some bacterial species produce histamine while others degrade it.

How iHeal evaluates and treats histamine intolerance

The evaluation considers dietary pattern, hormonal context, gut health, and the differential with MCAS. The clinical correlation matters most — a patient with a clear pattern of histamine-food triggers, hormonal cycle correlation, and response to histamine-directed intervention has functionally established histamine intolerance regardless of laboratory findings. Treatment combines histamine load reduction, DAO support, gut work to support endogenous DAO production, hormonal optimization when relevant, nutrient cofactor support, and addressing co-existing factors including MCAS when present.

Long-term, the goal is broadening diet tolerance rather than indefinite strict avoidance. With addressed gut health, hormonal balance, and reduced histamine load over time, many patients' tolerance for histamine-containing foods expands. The dietary restriction is treatment, not lifestyle.

Dr. Matthew Everett, MD

Pro Tip · From Dr. Everett

Matthew Everett, MDEnvironmental Medicine · IFMCP

The evaluation considers dietary pattern, hormonal context, gut health, and the differential with MCAS. The clinical correlation matters most — a patient with a clear pattern of histamine-food triggers, hormonal cycle correlation, and response to histamine-directed intervention has functionally established histamine intolerance regardless of laboratory findings. Treatment combines histamine load reduction, DAO support, gut work to support endogenous DAO production, hormonal optimization when relevant, nutrient cofactor support, and addressing co-existing factors including MCAS when present.

Sources & Further Reading

  • AAAAI: Mast Cell and Histamine-Related Conditions aaaai.org
  • Cleveland Clinic: Histamine Intolerance my.clevelandclinic.org/health/diseases/histamine-intolerance
  • Peer-Reviewed: DAO deficiency and histamine intolerance — PubMed-indexed; references in Inflammation Research, Allergy
  • Peer-Reviewed: Estrogen and histamine metabolism — PubMed-indexed; references in Maturitas, Climacteric

Concerned this applies to you?

A consultation is where we figure out whether histamine intolerance is actually contributing to your symptoms — and what to do about it.

Histamine Intolerance

Histamine intolerance and MCAS overlap clinically but they're not the same condition. The distinction matters for treatment — and most patients with food-triggered symptoms have one or the other, sometimes both.

What patients tell us

“I react to wine, aged cheese, leftovers, fermented foods. Headache, flushing, congestion, sometimes hives. The reactions are worse around my period. I've cut out the obvious foods and I'm better, but I'm not sure what's actually happening or how to broaden my diet again.”

What histamine intolerance is

Histamine intolerance describes a clinical pattern in which patients experience symptoms in response to histamine-containing foods or histamine-releasing triggers, attributed to an imbalance between histamine input and the body's capacity to break it down. The primary enzyme responsible for histamine degradation in the gut is diamine oxidase (DAO); secondary degradation occurs through histamine N-methyltransferase. When DAO activity is insufficient relative to histamine load, symptoms result.

Histamine is present in many foods — produced by bacterial fermentation in aged, cured, and fermented products, accumulated in foods that have been stored, and present naturally in some fresh foods. Other foods, while not high in histamine themselves, are histamine-releasing — they trigger mast cell degranulation that releases endogenous histamine.

Why histamine intolerance and MCAS aren't the same condition

Both conditions involve histamine, both produce similar symptoms in many patients, and both can coexist. MCAS is fundamentally about mast cell hyperactivity — mast cells releasing too many mediators in response to too many triggers; the treatment focus is mast cell stabilization. Histamine intolerance is more specifically about histamine balance — adequate intake or release of histamine overwhelming inadequate degradation capacity; the treatment focus is reducing histamine load and supporting degradation. In practice, the distinction is sometimes clean and sometimes not, and many patients fall in between, requiring clinical judgment.

The factors that affect DAO activity

Gut health is central — DAO is produced primarily in the small intestinal mucosa, and conditions affecting gut barrier function reduce DAO activity. Genetic variants affect baseline enzyme activity. Estrogen affects histamine metabolism — higher estrogen is associated with both increased histamine release and decreased DAO activity, which is why many patients experience worse symptoms during specific phases of the menstrual cycle. Certain medications inhibit DAO. Gut microbiome composition matters, as some bacterial species produce histamine while others degrade it.

How iHeal evaluates and treats histamine intolerance

The evaluation considers dietary pattern, hormonal context, gut health, and the differential with MCAS. The clinical correlation matters most — a patient with a clear pattern of histamine-food triggers, hormonal cycle correlation, and response to histamine-directed intervention has functionally established histamine intolerance regardless of laboratory findings. Treatment combines histamine load reduction, DAO support, gut work to support endogenous DAO production, hormonal optimization when relevant, nutrient cofactor support, and addressing co-existing factors including MCAS when present.

Long-term, the goal is broadening diet tolerance rather than indefinite strict avoidance. With addressed gut health, hormonal balance, and reduced histamine load over time, many patients' tolerance for histamine-containing foods expands. The dietary restriction is treatment, not lifestyle.

Dr. Matthew Everett, MD

Pro Tip · From Dr. Everett

Matthew Everett, MDEnvironmental Medicine · IFMCP

The evaluation considers dietary pattern, hormonal context, gut health, and the differential with MCAS. The clinical correlation matters most — a patient with a clear pattern of histamine-food triggers, hormonal cycle correlation, and response to histamine-directed intervention has functionally established histamine intolerance regardless of laboratory findings. Treatment combines histamine load reduction, DAO support, gut work to support endogenous DAO production, hormonal optimization when relevant, nutrient cofactor support, and addressing co-existing factors including MCAS when present.

Sources & Further Reading

  • AAAAI: Mast Cell and Histamine-Related Conditions aaaai.org
  • Cleveland Clinic: Histamine Intolerance my.clevelandclinic.org/health/diseases/histamine-intolerance
  • Peer-Reviewed: DAO deficiency and histamine intolerance — PubMed-indexed; references in Inflammation Research, Allergy
  • Peer-Reviewed: Estrogen and histamine metabolism — PubMed-indexed; references in Maturitas, Climacteric

Concerned this applies to you?

A consultation is where we figure out whether histamine intolerance is actually contributing to your symptoms — and what to do about it.